| URL | http://patch.com/massachusetts/woburn/pharmaceutic |
| Source | Woburn Patch |
| Date Published | 05/05/2015 |
| Author Name | Barry Thompson |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Continuus Pharmaceuticals |
| Parent company | Novartis |
| Type of work | Manufacturing |
| Reshoring category: | Transplant |
| Year reshoring announced: | 2015 |
| Capital investment ($): | 65 |
| Country(ies) from which reshored: | Switzerland |
| City reshored to: | Woburn |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Phrmaceuticals |
| What domestic positive factors made reshoring more attractive? | Manufacturing/engineering joint innovation (R&D) |